These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21937131)

  • 1. The short to mid-term effect of bone marrow derived cell transfer on diastolic function after acute myocardial infarction.
    Jiang M; Pu J; He B
    Int J Cardiol; 2011 Nov; 153(1):87-8. PubMed ID: 21937131
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
    Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H; Meyer GP; Wollert KC
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
    Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two year follow-up results of the CARDIAC (CARDIomyoplasty by Autologous intraCoronary bone marrow in acute myocardial infarction) randomised controlled trial.
    Piepoli MF; Vallisa D; Arbasi C; Cavanna L; Cerri L; Mori M; Passerini F; Tommasi L; Rossi A; Capucci A;
    Int J Cardiol; 2013 Oct; 168(5):e132. PubMed ID: 23992933
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial.
    Schaefer A; Meyer GP; Fuchs M; Klein G; Kaplan M; Wollert KC; Drexler H
    Eur Heart J; 2006 Apr; 27(8):929-35. PubMed ID: 16510465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiomyoplasty with autological mononuclear cells of the bone marrow in patients with acute myocardial infarction].
    Riabov VV; Suslova TE; Krylov AL; Poponina IuS; Vesnina ZhV; Sazonova SI; Markov VA; Popov SV; Karpov RS
    Ter Arkh; 2006; 78(8):47-52. PubMed ID: 17078217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
    Erbs S; Linke A; Schächinger V; Assmus B; Thiele H; Diederich KW; Hoffmann C; Dimmeler S; Tonn T; Hambrecht R; Zeiher AM; Schuler G
    Circulation; 2007 Jul; 116(4):366-74. PubMed ID: 17620510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial infarct trial of Düsseldorf. Short- and long-term results after intracoronary stem cell transplantation in acute and chronic myocardial infarction].
    Brehm M
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():193-4. PubMed ID: 16802553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Moum T; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Forfang K
    Am Heart J; 2007 Oct; 154(4):710.e1-8. PubMed ID: 17892996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stem cell transfer in myocardial infarction].
    Dimmeler S; Zeiher AM
    Dtsch Med Wochenschr; 2006 Apr; 131(16):881-3. PubMed ID: 16625481
    [No Abstract]   [Full Text] [Related]  

  • 13. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.
    Meluzín J; Janousek S; Mayer J; Groch L; Hornácek I; Hlinomaz O; Kala P; Panovský R; Prásek J; Kamínek M; Stanícek J; Klabusay M; Korístek Z; Navrátil M; Dusek L; Vinklárková J
    Int J Cardiol; 2008 Aug; 128(2):185-92. PubMed ID: 17764767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction.
    Guo HD; Cui GH; Wang HJ; Tan YZ
    Biochem Biophys Res Commun; 2010 Aug; 399(1):42-8. PubMed ID: 20637726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow cell therapy after myocardial infarction. What should we select?
    Landmesser U
    Eur Heart J; 2009 Jun; 30(11):1310-2. PubMed ID: 19429633
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of bone marrow-derived cells on diastolic function and exercise capacity in patients after acute myocardial infarction.
    Jiang M; Mao J; He B
    Stem Cell Res; 2012 Jul; 9(1):49-57. PubMed ID: 22640927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac accumulation of bone marrow mononuclear progenitor cells after intracoronary or intravenous injection in pigs subjected to acute myocardial infarction with subsequent reperfusion.
    Grøgaard HK; Sigurjonsson OE; Brekke M; Kløw NE; Landsverk KS; Lyberg T; Eriksen M; Egeland T; Ilebekk A
    Cardiovasc Revasc Med; 2007; 8(1):21-7. PubMed ID: 17293265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracoronary infusion of bone marrow-derived stem cells on pulmonary artery pressure and diastolic function after myocardial infarction.
    Miettinen JA; Salonen RJ; Niemelä M; Kervinen K; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Mäkikallio TH; Huikuri HV; Ylitalo KV
    Int J Cardiol; 2010 Dec; 145(3):631-3. PubMed ID: 20961630
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial.
    Schächinger V; Tonn T; Dimmeler S; Zeiher AM
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S23-8. PubMed ID: 16501626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.